| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/13/2001 | US6187573 DNA encoding a thermostable DNA polymerase |
| 02/13/2001 | US6187567 Methods and reagents for in situ amplification |
| 02/13/2001 | US6187566 Method of labeling a nucleic acid amplicon with simultaneous contamination prevention |
| 02/13/2001 | US6187562 Polynucleotides encoding human sphingosine Lyase |
| 02/13/2001 | US6187561 Nucleotide sequence coding enzymatic polypeptide associated with charging molecule during translation; for detection of bactericides; for antibiotic prophylaxis before dental treatment; for prevention of infections; wound healing agents |
| 02/13/2001 | US6187560 Nucleotide sequences coding mitochondrial polypeptide; for the treatment of dietetics, diabetes, hyperlipidemia and weight defects |
| 02/13/2001 | US6187556 Mixture of urea, potassium hydrogen phosphate, phenate, indicator and water |
| 02/13/2001 | US6187553 Eliminating physiological effects of heparin in blood mixture in blood recovery tube; preparing mixture of heparinase, trehalose and buffer, spray coat wall of tube, dry, remove oxygen, stopper, irradiate, add blood and allow to coagulate |
| 02/13/2001 | US6187552 Screening for enzyme inhibitors; incubating two preferential proteins with modulator, detect whether modulator prevents formation of complex between preferential proteins |
| 02/13/2001 | US6187546 From fecal stools; cooling to freezing point, removal cells |
| 02/13/2001 | US6187544 Propagation of nucleotide sequences; prepare nucleotides from messenger ribonucleic acids, separate nucleotide sequences by size, transform cells with nucleotide sequences, mix nucleotide sequences, isolate nucleotides of interest |
| 02/13/2001 | US6187543 Method of screening a compound for its ability to enhance the ability of tristetraprolin to inhibit tumor necrosis factor |
| 02/13/2001 | US6187542 Diagnosing humans with congestive heart failure; obtaining leukocyte sample, detecting mutation in gene coding hydrolase, the presence of mutation indicates sensitivity to congestive heart failure |
| 02/13/2001 | US6187541 Screening for bactericides; determining whether a test compound is a modulator of bacterial gene expression; bactericides |
| 02/13/2001 | US6187540 Accuracy in classification of infants; obtain infant cells, store cells in protective device, convey protective device to genotyping building, evaluate protective device for rupture, genotype sample, genotype second sample and compare |
| 02/13/2001 | US6187539 Applying to matched ion polynucleotide chromatograhy column; elution |
| 02/13/2001 | US6187538 Differential hybridization for relative quantification of variant populations |
| 02/13/2001 | US6187536 In vitro diagnosis of tumors in humans; analyzing preferential organ tissue for presence of cholecystokinin messenger ribonucleic acids, presence of cholecystokinin messenger ribonucleic acids indicates human has a tumor |
| 02/13/2001 | US6187535 Isolating preferential nucleotide sequences coding binding proteins; providing yeast cell mix, mate and plate yeast, isolate diploid yeast, classify nucleotide sequences in diploid yeast cell |
| 02/13/2001 | US6187534 Methods of evaluating transplant rejection |
| 02/13/2001 | US6187533 Screening for genome adjustments associated with non-insulin dependent diabetes; obtaining nucleotide sequences from human, analyze nucleotide sequences for genome adjustment, presence of genome adjustment indicates genetic disorders |
| 02/13/2001 | US6187532 Double-stranded conformational polymorphism analysis |
| 02/13/2001 | US6187531 Method for correcting for blood volume in a serum analyte determination |
| 02/13/2001 | US6187314 Provide a more accurately defined ginkgo biloba extract by further identifying individual components of the flavonoid compounds, determining the amount of the individual components and regulating the ratio among them. |
| 02/13/2001 | US6187310 Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kDa subunit multigene family |
| 02/13/2001 | US6187268 Device for colorimetric detection of analyte in test fluid comprising dry reagent layer overcoated with transparent, fluid permeable water swellable membrane |
| 02/13/2001 | CA2314595A1 A process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding for the sod gene |
| 02/13/2001 | CA2127117C Dna encoding a human serotonin receptor (5-ht4b) and uses thereof |
| 02/13/2001 | CA2105512C Enhanced detection of microorganisms in samples |
| 02/13/2001 | CA2028059C Process and reactives for sensing of microorganisms |
| 02/10/2001 | WO2001007580A1 Thermostable nucleoside diphosphate kinase for nucleic acid detection |
| 02/10/2001 | CA2359070A1 Thermostable nucleoside diphosphate kinase for nucleic acid detection |
| 02/08/2001 | WO2001009711A2 Methodology for identifying plants and other organisms having traits differing from a normal population |
| 02/08/2001 | WO2001009613A1 Method for screening molecules for the treatment of huntington disease |
| 02/08/2001 | WO2001009612A1 Modulating binding site on potassium channels used for screening |
| 02/08/2001 | WO2001009610A1 Method to measure acyl-coenzyme a esters |
| 02/08/2001 | WO2001009607A1 Microarrays and their manufacture |
| 02/08/2001 | WO2001009606A1 Methods for analyzing protein binding events |
| 02/08/2001 | WO2001009591A1 Method for optical excitation of fluorophore marked dna and rna |
| 02/08/2001 | WO2001009390A1 Tenascin-c nucleic acid ligands |
| 02/08/2001 | WO2001009389A2 Methods and apparatus for template capture and normalization for submicroliter reaction |
| 02/08/2001 | WO2001009388A1 Instruments, methods and reagents for surface plasmon resonance |
| 02/08/2001 | WO2001009387A1 Isolation of novel hemapoietic genes by representational difference analysis |
| 02/08/2001 | WO2001009386A2 Digital amplification |
| 02/08/2001 | WO2001009384A2 Serial analysis of genetic alterations |
| 02/08/2001 | WO2001009383A2 Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders |
| 02/08/2001 | WO2001009381A2 Methods of nucleic acid analysis by detecting molecular binding events |
| 02/08/2001 | WO2001009380A1 Transcription-free selex |
| 02/08/2001 | WO2001009378A1 Method for detecting nucleic acid in nucleic acid sample using micro well plate with various dna probes |
| 02/08/2001 | WO2001009377A1 Method for detecting nucleic acid target sequences involving in vitro transcription from an rna polymerase promoter |
| 02/08/2001 | WO2001009376A1 Method for amplification of nucleic acids |
| 02/08/2001 | WO2001009375A2 Inducible screen for drug discovery |
| 02/08/2001 | WO2001009374A2 Method for characterizing nucleic acid fragments |
| 02/08/2001 | WO2001009373A2 Native cdc25 substrates, compositions and uses related thereto |
| 02/08/2001 | WO2001009372A1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases |
| 02/08/2001 | WO2001009371A1 Apparatus and method for detecting, quantifying and characterizing microorganisms |
| 02/08/2001 | WO2001009370A2 Detection and identification of bacterial strains |
| 02/08/2001 | WO2001009369A2 Single-phase amplification of nucleic acids |
| 02/08/2001 | WO2001009367A1 Method of designing drugs through reverse polymorphism of target genes |
| 02/08/2001 | WO2001009347A2 Archaeal replication accessory factors and methods of use |
| 02/08/2001 | WO2001009343A1 Nuclease variant and their use in genotyping assays |
| 02/08/2001 | WO2001009341A2 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 02/08/2001 | WO2001009340A1 Proteins derived from white spot syndrome virus and uses thereof |
| 02/08/2001 | WO2001009336A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 02/08/2001 | WO2001009325A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | WO2001009313A1 G-protein coupled receptor and dna sequences thereof |
| 02/08/2001 | WO2001009311A2 Methods of inhibiting cancer cells with adnf iii antisense oligonucleotides |
| 02/08/2001 | WO2001009305A2 Purine metabolism genes in plants |
| 02/08/2001 | WO2001009292A2 Sentrin-specific human proteases senp1-3 |
| 02/08/2001 | WO2001009289A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 02/08/2001 | WO2001009281A1 Internal quality control |
| 02/08/2001 | WO2001009189A2 Compositions and methods for the treatment of tumors |
| 02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |
| 02/08/2001 | WO2001009183A2 Polymorphisms in the human mdr-1 gene and applications thereof |
| 02/08/2001 | WO2001009178A2 Human chaperone proteins |
| 02/08/2001 | WO2001009176A2 Mammalian cytokines; related reagents |
| 02/08/2001 | WO2001009170A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/08/2001 | WO2001009167A1 KdtB |
| 02/08/2001 | WO2001009161A1 Drug target isogenes: polymorphisms in the solute carrier family 6_neurotransmitter transporter, serotonin_, member 4 gene |
| 02/08/2001 | WO2001009160A1 Nucleic acid ligands to cd40ligand |
| 02/08/2001 | WO2001009159A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 02/08/2001 | WO2001009157A1 High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors |
| 02/08/2001 | WO2001009156A1 HIGH AFFINITY TGFη NUCLEIC ACID LIGANDS AND INHIBITORS |
| 02/08/2001 | WO2001008802A1 Low volume chemical and biochemical reaction system |
| 02/08/2001 | WO2001008720A2 Hypocretin and hypocretin receptors in regulation of sleep and related disorders |
| 02/08/2001 | WO2001008707A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 02/08/2001 | WO2001008676A1 Assay for d-serine transport antagonist and use for treating psychosis |
| 02/08/2001 | WO2001008635A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
| 02/08/2001 | WO2000075636B1 Multispectral taxonomic identification |
| 02/08/2001 | WO2000075317A3 Compositions and methods for the treatment of tumor |
| 02/08/2001 | WO2000073494B1 Culture medium for the detection of zygosaccharomyces |
| 02/08/2001 | WO2000067907A3 Sample evaporative control |
| 02/08/2001 | WO2000066771A3 Diagnostic sequencing by a combination of specific cleavage and mass spectrometry |
| 02/08/2001 | WO2000065039A3 Identification of dna control elements responsive to specific stimuli |
| 02/08/2001 | WO2000063667A3 Methods for identifying modulators of n-type ion channel inactivation |
| 02/08/2001 | WO2000063426A3 Compound screening methods |
| 02/08/2001 | WO2000063230A3 49 human secreted proteins |
| 02/08/2001 | WO2000061756A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |